HEMOGENYX PHARMACEUTICALS PLC O(HEMO)股吧_HEMOGENYX PHARMACEUTICALS PLC O怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
21	0	Notice of AGM	HEMOGENYX PHARMA资讯	06-05 02:17
19	0	Grant of Options and Extension of Warrant Term	HEMOGENYX PHARMA资讯	05-29 04:24
30	0	Final Results	HEMOGENYX PHARMA资讯	04-30 11:07
31	0	Institutional Fundraise	HEMOGENYX PHARMA资讯	04-28 02:30
30	0	Annual IND Report with FDA	HEMOGENYX PHARMA资讯	04-14 02:33
34	0	Tech Transfer Completion and Clinical Trial Update	HEMOGENYX PHARMA资讯	03-31 08:25
34	0	Total Voting Rights	HEMOGENYX PHARMA资讯	02-27 04:15
38	0	Holding(s) in Company	HEMOGENYX PHARMA资讯	02-24 03:39
47	0	Exercise of Warrants and Issue of Equity	HEMOGENYX PHARMA资讯	02-23 03:25
53	0	Issue of Equity - Correction	HEMOGENYX PHARMA资讯	02-10 11:57
41	0	Issue of Equity	HEMOGENYX PHARMA资讯	02-10 03:28
35	0	Total Voting Rights	HEMOGENYX PHARMA资讯	01-30 03:30
46	0	Holding(s) in Company	HEMOGENYX PHARMA资讯	01-12 03:21
41	0	Update on Admission of Shares	HEMOGENYX PHARMA资讯	12-22 04:02
42	0	Issue of Equity	HEMOGENYX PHARMA资讯	12-18 03:27
53	0	Holding(s) in Company	HEMOGENYX PHARMA资讯	12-08 08:52
53	0	Total Voting Rights	HEMOGENYX PHARMA资讯	11-28 03:18
53	0	Publication of Prospectus	HEMOGENYX PHARMA资讯	11-19 07:51
42	0	Clinical Trial Update and Grant of Share Awards	HEMOGENYX PHARMA资讯	10-29 03:16
43	0	Clearance to Initiate Pediatric Enrolment	HEMOGENYX PHARMA资讯	10-08 09:06
47	0	Total Voting Rights	HEMOGENYX PHARMA资讯	09-30 02:27
39	0	Half-year Report	HEMOGENYX PHARMA资讯	09-30 02:26
42	0	Hemogenyx Signs Letter of Intent	HEMOGENYX PHARMA资讯	09-23 02:27
54	0	Holding(s) in Company	HEMOGENYX PHARMA资讯	09-18 08:29
39	0	Third Patient Safety	HEMOGENYX PHARMA资讯	09-17 02:18
45	0	Invitation to Participate at DCNY Summit	HEMOGENYX PHARMA资讯	09-11 02:22
49	0	Manufacturing Partnership with Made Scientific	HEMOGENYX PHARMA资讯	09-08 02:31
46	0	Exercise of Warrants and Issue of Equity	HEMOGENYX PHARMA资讯	09-05 02:21
52	0	Exercise of Warrants and Issue of Equity	HEMOGENYX PHARMA资讯	09-03 09:00
60	0	Issue of convertible loan notes	HEMOGENYX PHARMA资讯	09-01 10:11
59	0	Result of Audit Tender	HEMOGENYX PHARMA资讯	08-29 02:20
52	0	Hemogenyx raises ￡570,000 and Director's Dealing	HEMOGENYX PHARMA资讯	08-26 06:47
42	0	Third Patient Treated with HG-CT-1 CAR-T Therapy	HEMOGENYX PHARMA资讯	08-15 02:16
44	0	Total Voting Rights	HEMOGENYX PHARMA资讯	07-31 02:27
61	0	Placing to Raise ￡250,000 and Director’s Dealing	HEMOGENYX PHARMA资讯	07-29 03:04
54	0	Hemogenyx Awarded Grant	HEMOGENYX PHARMA资讯	07-16 02:22
43	0	Total Voting Rights	HEMOGENYX PHARMA资讯	06-30 02:15
41	0	Clearance to Proceed with Pediatric Expansion	HEMOGENYX PHARMA资讯	06-17 02:16
67	0	Placing to Raise ￡451,250 and Director’s Dealing	HEMOGENYX PHARMA资讯	06-03 09:05
63	0	Second Patient Passes Initial Safety Tests	HEMOGENYX PHARMA资讯	06-03 02:29
62	0	Total Voting Rights	HEMOGENYX PHARMA资讯	05-30 10:18
72	0	Result of AGM	HEMOGENYX PHARMA资讯	05-29 09:09
48	0	Pediatric Amendment to Clinical Protocol	HEMOGENYX PHARMA资讯	05-14 02:19
52	0	AGM Correction	HEMOGENYX PHARMA资讯	05-13 02:15
66	0	Placing to Raise ￡451,250 and Director’s Dealing	HEMOGENYX PHARMA资讯	05-08 02:20
86	0	Notice of AGM	HEMOGENYX PHARMA资讯	05-02 11:26
63	0	Second Patient Treated with HG-CT-1 CAR-T Therapy	HEMOGENYX PHARMA资讯	05-02 02:14
59	0	Final Results	HEMOGENYX PHARMA资讯	04-28 02:14
67	0	FDA Annual Report	HEMOGENYX PHARMA资讯	04-03 03:10
56	0	Total Voting Rights	HEMOGENYX PHARMA资讯	03-31 02:22
47	0	First Patient Safety	HEMOGENYX PHARMA资讯	03-24 03:17
48	0	Recruitment of Second Patient for Clinical Trials	HEMOGENYX PHARMA资讯	03-17 03:20
61	0	Conversion of convertible loan notes	HEMOGENYX PHARMA资讯	03-13 11:13
56	0	Institutional investment	HEMOGENYX PHARMA资讯	03-11 03:25
67	0	First-in-Human Treatment with HG-CT-1	HEMOGENYX PHARMA资讯	02-24 03:18
68	0	Issue of convertible loan notes	HEMOGENYX PHARMA资讯	02-20 12:54
83	0	Total Voting Rights	HEMOGENYX PHARMA资讯	01-31 05:38
77	0	Placing to raise ￡340,000	HEMOGENYX PHARMA资讯	01-08 03:12
80	0	Change of Company Secretary and Registered Office	HEMOGENYX PHARMA资讯	01-02 03:18
68	0	Total Voting Rights	HEMOGENYX PHARMA资讯	12-31 03:09
82	0	Opening of First Clinical Site	HEMOGENYX PHARMA资讯	12-30 03:09
93	0	Ultrafast CAR-T Manufacturing	HEMOGENYX PHARMA资讯	12-19 03:16
82	0	Admission of New Ordinary Shares and New ISIN	HEMOGENYX PHARMA资讯	12-11 12:13
102	0	Result of Extraordinary General Meeting	HEMOGENYX PHARMA资讯	12-09 09:33
77	0	Site Initiation Visit Completed	HEMOGENYX PHARMA资讯	12-09 03:09
82	0	CBR Macrophage Delivery Update	HEMOGENYX PHARMA资讯	12-06 03:12
90	0	Total Voting Rights	HEMOGENYX PHARMA资讯	11-29 03:14
84	0	Notice of Extraordinary General Meeting	HEMOGENYX PHARMA资讯	11-22 08:51
73	0	IRB Approval for Phase I Clinical Trial	HEMOGENYX PHARMA资讯	11-22 03:16
87	0	Institutional Investment	HEMOGENYX PHARMA资讯	11-11 03:15
89	0	Schedule for Phase I Clinical Trial Opening	HEMOGENYX PHARMA资讯	10-30 03:16
101	0	Strategic Investment from Prevail Partners, LLC	HEMOGENYX PHARMA资讯	10-02 06:21
88	0	Half-year Report	HEMOGENYX PHARMA资讯	09-27 02:16
92	0	FLT3 Assay Ready for Phase I Trials at MD Anderson	HEMOGENYX PHARMA资讯	09-09 02:16
74	0	CDX Development Update	HEMOGENYX PHARMA资讯	09-02 02:16
78	0	Presentation at CBD S&T Conference	HEMOGENYX PHARMA资讯	08-28 03:07
77	0	Macrophage-Directed Therapies Summit Presentation	HEMOGENYX PHARMA资讯	07-29 02:08
93	0	Result of Annual General Meeting	HEMOGENYX PHARMA资讯	06-28 12:48
104	0	Operations Update	HEMOGENYX PHARMA资讯	06-17 03:10
91	0	Posting of Annual Report & Notice of AGM	HEMOGENYX PHARMA资讯	06-03 03:09

emytylist